Omnia SanaPlant Comparison
Hemp vs Clove
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Hemp and Clove: they share 6 indicated uses (arthritis / joint pain, back pain, headache, …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Hemp | Clove | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 5/10 | 2/10 | Stronger for Hemp |
| Back pain | 5/10 | 1/10 | Stronger for Hemp |
| Headache | 5/10 | 1/10 | Stronger for Hemp |
| Inflammation (general) | 5/10 | 1/10 | Stronger for Hemp |
| Pain (general) | 5/10 | 1/10 | Stronger for Hemp |
| Skin irritation | 5/10 | 1/10 | Stronger for Hemp |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
The characteristic bioactive compounds of the resin-bearing flowers, varying widely in ratio and concentration between cultivars; THC is psychoactive, CBD is not.
Aromatic terpenes contribute to the plant's characteristic scent and may modulate cannabinoid effects.
Hemp seed is rich in polyunsaturated fatty acids (including omega-3 and omega-6), giving the pressed seed oil its nutritional value; essentially free of psychoactive cannabinoids.
Eugenol typically makes up the great majority of clove oil and is responsible for most of its analgesic, antimicrobial and anti-inflammatory activity.
Pharmacological Actions
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from sedative action
inferred from anti-inflammatory action
inferred from anticancer action
inferred from digestive action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Industrial hemp (low-THC cannabis) seed oil and seeds are generally safe as food. CBD products derived from hemp may interact with medications metabolised by cytochrome P450 liver enzymes, including common anticoagulants, antiepileptics, and immunosuppressants. THC-containing preparations impair driving and are regulated or prohibited in many jurisdictions. Not recommended during pregnancy or breastfeeding. Quality and cannabinoid content vary widely between hemp products.
Duke (2002) rates cannabis as ++ and notes clinical evidence (score 2) for its antiemetic activity, especially relevant for chemotherapy-induced nausea. Score 1 activities include analgesic, anticonvulsant, and anti-inflammatory properties. Duke highlights the legal and pharmacological complexity, noting THC as the primary psychoactive compound. Medically, synthetic cannabinoids (dronabinol, nabilone) are clinically approved for nausea and anorexia. Duke cautions that while the plant has genuine therapeutic potential, psychoactive effects, legal restrictions, and risk of dependence with regular use must be considered (Duke, 2002).
Strong and concentrated: Clove oil is very potent and should always be diluted before skin or mouth use.Dental use: Undiluted clove oil can burn gums or skin.Blood thinning: Clove may increase bleeding risk in large amounts or with anticoagulants.Pregnancy: Culinary amounts are fine; medicinal doses should be used cautiously.Children: Essential oil should be used with extra caution and diluted well.
Duke (2002) rates cloves as +++ with clinical evidence (score 2) for analgesic activity — specifically, topical application of clove oil (eugenol) for dental pain is clinically validated. The plant also shows strong antimicrobial, antifungal (anti-Candida), antispasmodic, and antiviral activities at the experimental level. Commission E approves topical clove preparations for dental pain. Recommended dose: 1–5% clove oil preparation (topical) or 150 mg clove powder internally. The essential oil is irritating to mucous membranes and should not be applied undiluted to skin or mucous membranes (Duke, 2002).
External Ids
Botanical Description
Erect annual herb with a distinctive palmately compound leaf of narrow, serrated leaflets. The plant is usually dioecious (separate male and female plants); female plants develop dense, resinous flower clusters, while male plants bear looser pollen-releasing flowers. The seed (achene) is small, hard-shelled and oil-rich.[14]
Evergreen tree (Myrtaceae), 8-12 m tall (occasionally to 20 m), with a pyramidal crown. Leaves are glossy, elliptical and aromatic. Small crimson flowers are borne in terminal clusters; the unopened flower buds, picked before they open and dried, are the 'cloves' of commerce and the medicinal/culinary part used.[2]
Habitat
Believed native to Central Asia; now cultivated worldwide, with industrial hemp (low-THC cultivars) grown in temperate climates for fibre, seed and cannabinoid extraction, subject to varying legal regulation by jurisdiction.[14]
Native to the Maluku Islands (Moluccas, the historic 'Spice Islands') of Indonesia, now cultivated throughout the tropics, notably Zanzibar, Madagascar, Sri Lanka and Indonesia, in warm, humid, well-drained tropical conditions.[2]
Harvesting
Flowers (and resin-bearing leaves) are harvested at peak resin/cannabinoid content, typically as the flower clusters mature in late summer to autumn; seed is harvested once mature and dried, then pressed for oil or used whole.[14]
Unopened flower buds are hand-picked while still green-pink, just before they would open, then sun-dried until they turn dark reddish-brown - the familiar clove spice.[2]
Traditional Uses
Cannabis/hemp has a long multi-cultural history as a fibre, food and medicinal plant, traditionally used for pain, muscle spasm, sleep and appetite, alongside industrial use of the fibre and seed. Modern cannabinoid research, particularly on THC and CBD, has substantially expanded the evidence base for pain, spasticity and specific seizure disorders.[14, 15]
Clove has an ancient trade history and a long traditional use across Asian, African and European medicine as a dental analgesic (chewed or applied as oil for toothache), a digestive carminative, and an antiseptic. Modern research on its principal constituent eugenol supports strong analgesic, antimicrobial, antioxidant and anti-inflammatory activity, with clove oil remaining a recognised topical dental-pain remedy.[2]
Preparations
Whole or hulled seed, or cold-pressed seed oil, used as a nutritional food source (essentially free of psychoactive cannabinoids).
Extract standardised to specific cannabinoid content (e.g. CBD), used in regulated medicinal products; regulatory status varies widely by jurisdiction and product type.
References
Drug Class Interactions
Not documented
Lookalikes Review
Dosage
References & Sources
- Rock, E.M. and Parker, L.A (2021) 'Constituents of Cannabis sativa', Advances in Experimental Medicine and Biology, 1264, pp. 1-13. doi:10.1007/978-3-030-57369-0_1 Traditional / reference
https://doi.org/10.1007/978-3-030-57369-0_1 - Castillo-Arellano, J., Canseco-Alba, A., Cutler, S.J. and León, F (2023) 'The Polypharmacological Effects of Cannabidiol', Molecules, 28(7), pp. 3271. doi:10.3390/molecules28073271 Traditional / reference
https://doi.org/10.3390/molecules28073271 - Pagano, C., Navarra, G., Coppola, L., Avilia, G. et al (2022) 'Cannabinoids: Therapeutic Use in Clinical Practice', International Journal of Molecular Sciences, 23(6), pp. 3344. doi:10.3390/ijms23063344 Traditional / reference
https://doi.org/10.3390/ijms23063344 - ElSohly, M.A., Radwan, M.M., Gul, W., Chandra, S. and Galal, A (2017) 'Phytochemistry of Cannabis sativa L', Progress in the Chemistry of Organic Natural Products, 103, pp. 1-36. doi:10.1007/978-3-319-45541-9_1 Meta-analysis / review
https://doi.org/10.1007/978-3-319-45541-9_1 - Viana, M.D.B., de Aquino, P.E.A., Estadella, D., Ribeiro, D.A. and Viana, G.S.D.B (2022) 'Cannabis sativa and cannabidiol: a therapeutic strategy for the treatment of neurodegenerative diseases?', Medical Cannabis and Cannabinoids, 5(1), pp. 207-219. doi:10.1159/000527335 Meta-analysis / review
https://doi.org/10.1159/000527335 - Alves, P., Amaral, C., Teixeira, N. and Correia-da-Silva, G (2020) 'Cannabis sativa: much more beyond delta-9-tetrahydrocannabinol', Pharmacological Research, 157, pp. 104822. doi:10.1016/j.phrs.2020.104822 Meta-analysis / review
https://doi.org/10.1016/j.phrs.2020.104822 - Odieka, A.E., Obuzor, G.U., Oyedeji, O.O., Gondwe, M., Hosu, Y.S. and Oyedeji, A.O (2022) 'The medicinal natural products of Cannabis sativa Linn.: a review', Molecules, 27(5), pp. 1689. doi:10.3390/molecules27051689 Meta-analysis / review
https://doi.org/10.3390/molecules27051689 - Nuutinen, T (2018) 'Medicinal properties of terpenes found in Cannabis sativa and Humulus lupulus', European Journal of Medicinal Chemistry, 157, pp. 198-228. doi:10.1016/j.ejmech.2018.07.076 Meta-analysis / review
https://doi.org/10.1016/j.ejmech.2018.07.076 - Liktor-Busa, E., Keresztes, A., LaVigne, J., Streicher, J.M. and Largent-Milnes, T.M (2021) 'Analgesic potential of terpenes derived from Cannabis sativa', Pharmacological Reviews, 73(4), pp. 98-126. doi:10.1124/pharmrev.120.000046 Meta-analysis / review
https://doi.org/10.1124/pharmrev.120.000046 - Martinelli, G., Magnavacca, A., Fumagalli, M., Dell'Agli, M., Piazza, S. and Sangiovanni, E (2021) 'Cannabis sativa and skin health: dissecting the role of phytocannabinoids', Planta Medica, 88(7), pp. 492-506. doi:10.1055/a-1420-5780 Meta-analysis / review
https://doi.org/10.1055/a-1420-5780 - Andre, C.M., Hausman, J.F. and Guerriero, G (2016) 'Cannabis sativa: the plant of the thousand and one molecules', Frontiers in Plant Science, 7, pp. 19. doi:10.3389/fpls.2016.00019 Meta-analysis / review
https://doi.org/10.3389/fpls.2016.00019 - Bonini, S.A., Premoli, M., Tambaro, S., Kumar, A., Maccarinelli, G., Memo, M. and Mastinu, A (2018) 'Cannabis sativa: a comprehensive ethnopharmacological review of a medicinal plant with a long history', Journal of Ethnopharmacology, 227, pp. 300-315. doi:10.1016/j.jep.2018.09.004 Meta-analysis / review
https://doi.org/10.1016/j.jep.2018.09.004 - Bergamaschi, M.M., Queiroz, R.H.C., Zuardi, A.W. and Crippa, J.A.S (2011) 'Safety and side effects of cannabidiol, a Cannabis sativa constituent', Current Drug Safety, 6(4), pp. 237-249. doi:10.2174/157488611798280924 Meta-analysis / review
https://doi.org/10.2174/157488611798280924 - Cerino, P., Buonerba, C., Cannazza, G. et al (2021) 'A review of hemp as food and nutritional supplement', 6(1), pp. 19--27. doi:10.1089/can.2020.0001 Preclinical
https://doi.org/10.1089/can.2020.0001 - Devinsky, O., Cross, J.H., Laux, L. et al (2017) 'Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome', 376(21), pp. 2011--2020. Randomized trial
https://scholar.google.com/scholar?q=Trial%20of%20cannabidiol%20for%20drug-resistant%20seizures%20in%20the%20Dravet%20syndrome - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Talwar, A., Estes, E., Aparasu, R. and Reddy, D.S (2022) 'Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis', Experimental Neurology, 359, pp. 114238. doi:10.1016/j.expneurol.2022.114238 Meta-analysis / review
https://doi.org/10.1016/j.expneurol.2022.114238 - Caus, M.N., Lupoae, M. and Chitescu, C.L (2026) 'Efficacy and Safety of Herbal Supplements with Anxiolytic, Antidepressant, and Sedative Action: A Review of Clinical Data and Toxicological Risks', Pharmaceuticals, 19(3), pp. 399. doi:10.3390/ph19030399 Meta-analysis / review
https://doi.org/10.3390/ph19030399
- Haro-Gonzalez, J.N., Castillo-Herrera, G.A., Martinez-Velazquez, M. and Espinosa-Andrews, H (2021) 'Clove Essential Oil (Syzygium aromaticum L. Myrtaceae): Extraction, Chemical Composition, Food Applications, and Essential Bioactivity for Human Health', Molecules, 26(21), pp. 6387. doi:10.3390/molecules26216387 Meta-analysis / review
https://doi.org/10.3390/molecules26216387 - Batiha, G.E., Alkazmi, L.M., Wasef, L.G., Beshbishy, A.M. and others (2020) 'Syzygium aromaticum L. (Myrtaceae): Traditional Uses, Bioactive Chemical Constituents, Pharmacological and Toxicological Activities', Biomolecules, 10(2), pp. 202. doi:10.3390/biom10020202 Meta-analysis / review
https://doi.org/10.3390/biom10020202 - Vicidomini, C., Roviello, V. and Roviello, G.N (2021) 'Molecular Basis of the Therapeutical Potential of Clove (Syzygium aromaticum L.) and Clues to Its Anti-COVID-19 Utility', Molecules, 26(7), pp. 1880. doi:10.3390/molecules26071880 Meta-analysis / review
https://doi.org/10.3390/molecules26071880 - Irahal, I.N., Guenaou, I., Lahlou, F.A., Hmimid, F. and others (2022) 'Syzygium aromaticum bud (clove) essential oil is a novel and safe aldose reductase inhibitor: in silico, in vitro, and in vivo evidence', Hormones (Athens), 21(2), pp. 229-240. doi:10.1007/s42000-021-00347-6 Preclinical
https://doi.org/10.1007/s42000-021-00347-6 - Yassin, M.T., Mostafa, A.A. and Al-Askar, A.A (2020) 'In vitro anticandidal potency of Syzygium aromaticum (clove) extracts against vaginal candidiasis', BMC Complementary Medicine and Therapies, 20(1), pp. 25. doi:10.1186/s12906-020-2818-8 Preclinical
https://doi.org/10.1186/s12906-020-2818-8 - Kiki, M.J (2023) 'In Vitro Antiviral Potential, Antioxidant, and Chemical Composition of Clove (Syzygium aromaticum) Essential Oil', Molecules, 28(6), pp. 2421. doi:10.3390/molecules28062421 Preclinical
https://doi.org/10.3390/molecules28062421 - Radunz, M., da Trindade, M.L.M., Camargo, T.M., Radunz, A.L. and others (2019) 'Antimicrobial and antioxidant activity of unencapsulated and encapsulated clove (Syzygium aromaticum, L.) essential oil', Food Chemistry, 276, pp. 180-186. doi:10.1016/j.foodchem.2018.09.173 Preclinical
https://doi.org/10.1016/j.foodchem.2018.09.173 - Shakeel, F., Alam, P., Ali, A., Alqarni, M.H. and others (2021) 'Investigating Antiarthritic Potential of Nanostructured Clove Oil (Syzygium aromaticum) in FCA-Induced Arthritic Rats: Pharmaceutical Action and Delivery Strategies', Molecules, 26(23), pp. 7327. doi:10.3390/molecules26237327 Preclinical
https://doi.org/10.3390/molecules26237327 - Tu, Z., Moss-Pierce, T., Ford, P. and Jiang, T.A (2014) 'Syzygium aromaticum L. (Clove) extract regulates energy metabolism in myocytes', Journal of Medicinal Food, 17(9), pp. 1003-1010. doi:10.1089/jmf.2013.0175 Preclinical
https://doi.org/10.1089/jmf.2013.0175 - Banerjee, S., Panda, C.K. and Das, S (2006) 'Clove (Syzygium aromaticum L.), a potential chemopreventive agent for lung cancer', Carcinogenesis, 27(8), pp. 1645-1654. doi:10.1093/carcin/bgi372 Preclinical
https://doi.org/10.1093/carcin/bgi372 - Bhowmik, D., Kumar, K.P.S., Yadav, A., Srivastava, S., Paswan, S. and Dutta, A.S (2012) 'Recent trends in Indian traditional herbs Syzygium aromaticum and its health benefits', 1(1), pp. 13--23. Traditional / reference
https://scholar.google.com/scholar?q=Recent%20trends%20in%20Indian%20traditional%20herbs%20Syzygium%20aromaticum%20and%20its%20health%20benefits - Royal Botanic Gardens, Kew (n.d.). Available at: https://powo.science.kew.org Traditional / reference
https://powo.science.kew.org - World Health Organization (2002) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.